The introduction of nicotinamide as being a nicotine alternative in e-cigarette and smokeless products and solutions represents a significant regulatory challenge for that FDA. Nicotinamide does not have nicotinic receptor agonist exercise and is known to act as a sedative at significant dosages6. The statements made by Nicotine River, ECBlend, tog